Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. (Q46289012)
Jump to navigation
Jump to search
scientific article published on 28 October 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. |
scientific article published on 28 October 2008 |
Statements
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial (English)
W H Ludlam
B Atkinson
J E Glusman
S Petersenn
M Reincke
P Snyder
A Tabarin
B M K Biller
J Findling
S Melmed
C H Darby
K Hu
Y Wang
P U Freda
L A Frohman
28 October 2008